GSK 221458
Android app by Medable Inc.. Medical · Medable Inc.
- Store rating
- Unknown
- Store rating count
- Unknown
- Download price
- Free to download
- In-app purchases
- Not listed in captured metadata
- Version
- 5.4.800.15-prod
- Listing last refreshed
- 2026-09-14
View the original store listing
Store description excerpt
This app is specifically intended for participants in the GSK 221458 study only. It contains Televisit functionality and allows participants to complete questionnaires. The study is a Phase 1, first-time-in-human, three-part study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of GSK4527363 in healthy participants (Part A), participants with active systemic lupus erythematosus (Part B), and healthy participants of Chinese and Japanese descent (Part C). (Televisit tasks are not enabled by default and may be enabled as needed, by study officials.)
Review coverage
AppRill has captured 0 reviews for this app. This is a collected sample, separate from the store rating count. Latest review capture: Not captured yet.
Recent captured chart positions
No chart positions have been captured for this app yet.
Chart position, rating count and review coverage do not establish downloads, revenue or profit. Understand the differences.